↓ Skip to main content

Dove Medical Press

Management of cytopenias in patients with myelofibrosis treated with ruxolitinib and effect of dose modifications on efficacy outcomes

Overview of attention for article published in OncoTargets and therapy, December 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
51 Dimensions

Readers on

mendeley
37 Mendeley
Title
Management of cytopenias in patients with myelofibrosis treated with ruxolitinib and effect of dose modifications on efficacy outcomes
Published in
OncoTargets and therapy, December 2013
DOI 10.2147/ott.s53348
Pubmed ID
Authors

Srdan Verstovsek, Jason Gotlib, Vikas Gupta, Ehab Atallah, John Mascarenhas, Alfonso Quintas-Cardama, William Sun, Nicholas J Sarlis, Victor Sandor, Richard S Levy, Hagop M Kantarjian, Ruben A Mesa

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Peru 1 3%
Unknown 36 97%

Demographic breakdown

Readers by professional status Count As %
Other 6 16%
Researcher 6 16%
Student > Master 5 14%
Student > Doctoral Student 2 5%
Student > Ph. D. Student 2 5%
Other 4 11%
Unknown 12 32%
Readers by discipline Count As %
Medicine and Dentistry 14 38%
Biochemistry, Genetics and Molecular Biology 4 11%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Agricultural and Biological Sciences 2 5%
Nursing and Health Professions 1 3%
Other 2 5%
Unknown 12 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 March 2022.
All research outputs
#8,535,472
of 25,374,647 outputs
Outputs from OncoTargets and therapy
#547
of 3,016 outputs
Outputs of similar age
#97,159
of 320,964 outputs
Outputs of similar age from OncoTargets and therapy
#8
of 23 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 320,964 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.